Integrated test device for optical detection of microarrays

• US 9,140,693 B2
• Filed: 12/21/2012
• Issued: 09/22/2015
• Est. Priority Date: 12/23/2011
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Ewart, Thomas, Davis, Graham, Emeric, Pierre, Gershtein, Sergey, Sutrala, Smitha, Di Tullio, Katrina
• Primary Examiner(s): Hyun, Paul
• Assistant Examiner(s): EOM, ROBERT J
• Application Number:
  US13/724,370
• Publication Number:
  US 20130184188A1
• Time in Patent Office: 1,005 Days
• Field of Search: 422/52, 422/68.1, 422/82.01, 422/82.02, 422/82.05, 422500-505
• US Class Current: 1/1
• CPC Class Codes: G01N 2035/00108 Test strips, e.g. paper
• CPC Class Codes: G01N 2035/00128 with pressing or squeezing devices
• CPC Class Codes: G01N 21/253 for batch operation, i.e. multisample apparatus analytical automats G01N35/00
• CPC Class Codes: G01N 21/6452 Individual samples arranged in a regular 2D-array, e.g. multiwell plates
• CPC Class Codes: G01N 33/492 Determining multiple analytes
• CPC Class Codes: G01N 33/53 Immunoassay; Biospecific binding assay; Materials therefor
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 35/00029 provided with flat sample substrates, e.g. slides G01N35/028 takes precedence

Abstract

This invention relates generally to devices and methods for performing optical and electrochemical assays and, more particularly, to testing devices having an optically readable microspot array and/or an electrochemical detector and to methods of performing microspot arrays and electrochemical assays using such devices. The present invention is particularly useful for performing immunoassays and/or electrochemical assays at the point-of-care.

Claims

1. A testing cartridge for detection of an analyte in a test sample, said testing cartridge comprising:

an entry port configured to receive a test sample into a holding chamber;

at least one electrochemical sensor;

an optically readable microspot array;

a first conduit fluidically connected to the holding chamber and configured to receive the test sample from the holding chamber, the first conduit comprising said at least one electrochemical sensor;

a second conduit fluidically connected to the first conduit and configured to receive the test sample from the first conduit, the second conduit comprising said optically readable microspot array; and

a plurality of conductivity sensors configured to determine a position of said test sample in said first and second conduit.

2. The testing cartridge of claim 1, further comprising a barcode that comprises information identifying at least one of:

said testing cartridge, an electrochemical test performed by said testing cartridge, and at least one microspot array test performed by said testing cartridge.

3. The testing cartridge of claim 1, wherein said microspot array comprises a qualitative or semi-quantitative test for said analyte.

4. The testing cartridge of claim 3, wherein said qualitative or semi-quantitative microspot array is configured to detect said analyte selected from the group consisting of:

drugs of abuse, classes of cytokines, and inflammatory markers.

5. The testing cartridge of claim 1, wherein said electrochemical sensor is configured to detect said analyte selected from the group consisting of:

hCG, K, Na, Cl, Ca, Mg, pH, pO₂, pCO₂, glucose, urea, creatinine, lactate, CKMB, TnI, TnT, BNP, NTproBNP, proBNP, TSH, D-dimer, PSA, PTH, NGAL, galectin-3, AST, ALT, albumin, phosphate, and ALP.

6. The testing cartridge of claim 1, further comprising an imager chip configured to capture an image of said optically readable microspot array.

7. The testing cartridge of claim 6, wherein said imager chip is a silicon biosensor chip configured to measure a light output of at least one photochemical reaction on said optically readable microspot array.

8. The testing cartridge of claim 1, wherein said optically readable microspot array comprises at least one spot that is a quantum dot.

9. The testing cartridge of claim 1, wherein said optically readable microspot array comprises at least one spot that is a quantum dot or a nanoparticle having properties of fluorescence or phosphorescence singly or in combination with magnetic or paramagnetic properties.

10. The testing cartridge of claim 1, wherein said optically readable microspot array comprises a plurality of spots in a plurality of columns and a plurality of rows.

11. The testing cartridge of claim 1, wherein said optically readable microspot array comprises a plurality of spots that are substantially circular and have a diameter in a range of about 10 um to about 500 um.

12. The testing cartridge of claim 1, further comprising a wash fluid reservoir with a displacement device configured to move a fluid from said wash fluid reservoir into the second conduit comprising said optically readable microspot array and washing said test sample from said optically readable microspot array.

13. The testing cartridge of claim 12, wherein a volume of said fluid is in a range of about 10 μ

L to about 500 μ

L.

14. The testing cartridge of claim 13, wherein a volume of said test sample is in a range of about 1 μ

L to about 100 μ

L.

15. The testing cartridge of claim 1, where said optically readable microspot array comprises at least one immobilized antibody.

16. The testing cartridge of claim 15, wherein said at least one immobilized antibody is configured to bind with said analyte selected from the group consisting of:

D-dimer, HSA, inflammatory and traumatic disease markers including C-reactive protein, NGAL, D-dimer, TNFa, TGFb, IL-1 and IL6;

metabolic disease indicators including HSA, liver enzymes ALP, ALT, AST, bilirubin, vitamine-D, vitamine-B12, and folic acid;

protein hormones including TSH, hCG, LH, FSH, prolactin, insulin, and somatostatin;

cardiac disease markers including cardiac troponins, CK-MB, BNP and Galectin-3;

tumor markers including PSA, CEA, AFP, CA125, VEGF, BrCa1, and HER2/neu;

hormones including T3, T4, DHEA, estrogen, and progesterone;

infectious diseases organisms and/or plasma antibodies against infectious disease organisms including Hepatitis B, HIV, Influenzas A and B, West Nile Virus, Epstein-Barr Virus, Parvovirus, Ebola Virus, Sindbis Virus, Chlamydia, Respiratory Syncytial Virus, Pseudomonas, Klebsiella, Serratia, Salmonella, Bartonella, Giardia, Cryptosporidium, Gonococcus and Treponema;

autoimmune disease markers including Ro-52, vimentin, RNP-Sm, MBP, Jo-1, Sc1-70, gliadin, aquaporin, and cardiolipin; and

drugs of the general grouping antibiotics, antivirals, antiepileptics, antidepressants, narcotics, and immunosuppressives.

17. A testing cartridge for detection of an analyte in a test sample, said testing cartridge comprising:

an entry port for receiving said test sample into a holding chamber;

a first conduit comprising at least one electrochemical sensor, wherein the first conduit is fluidically connected to the holding chamber and configured to receive said test sample from the holding chamber;

a second conduit comprising an optically readable microspot array, wherein the second conduit is fluidically connected to the first conduit and configured to receive said test sample from the first conduit;

a microfluidic circuit comprising a plurality of conductivity sensors configured to determine a position of said test sample in said first and second conduit; and

a pump connected to the microfluidic circuit and configured to automatically move said test sample from the holding chamber into the first conduit until a conductance or impedance change indicates said test sample is bridging a first pair of said plurality of conductivity sensors, and subsequently move said test sample from the first conduit into the second conduit until the conductance or impedance change indicates said test sample is bridging a second pair of said plurality of conductivity sensors.

18. The testing cartridge of claim 17, further comprising a barcode that comprises information identifying at least one of:

said testing cartridge, an electrochemical test performed by said testing cartridge, and at least one microspot array test performed by said testing cartridge.

19. The testing cartridge of claim 18, further comprising an imager chip configured to capture an image of said optically readable microspot array and said barcode at a same time.

20. An analyte test cartridge comprising:

a sample entry port configured to receive a test sample;

a conduit comprising an optically readable microspot array;

a microfluidic circuit comprising a plurality of conductivity sensors configured to determine a first position of said test sample at an inlet of the optically readable microspot array based on a conductance or impedance change that indicates said test sample is bridging a first pair of said plurality of conductivity sensors, and a second position of said test sample over the optically readable microspot array based on a conductance or impedance change that indicates said test sample is bridging a second pair of said plurality of conductivity sensors; and

a displacement device connected to the microfluidic circuit and configured to move said test sample from the sample entry port into the conduit based on the determined first position and second position,

wherein said sample entry port is connected to said optically readable microspot.